SUMMARY.-The results of treating two series of patients with Burkitt's lymphoma are presented in the form of survival curves. The second series shows an improved survival rate which seems to be due to a potentiating effect by potassium iodide on oral cyclophosphamide. So far no reason for this effect has been found.
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.l P,. .l 44 tv, X 00 to 10 10 10 1* . 1. (Burkitt et al., 1969) , but the reason why so many patients with Burkitt's lymphoma have been treated here rather than at a specialised centre has been that such a centre is 300 miles away by bus. Patients are often too ill to take a long bus journey and also parents, will often refuse to take their child so far away from home. The only difference in the treatment of these two series has been the addition of potassium iodide to the therapeutic regime in Series 11. Three other possible differences are examined as follows:
(1) Comparison of total average dosaae -per patient of cyclophosphamide.
In Series I this was 3.4 g. and in Series 11, 3-1 g.
(2) Comparison of number of courses of treatment. 
